ST. PAUL, Minn., Nov. 1, 2016 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Sachin Kukreja, M.D., Director of Bariatric Surgery, VA North Texas Health Care System, will perform a live adjunctive rescue surgery for a failed gastric sleeve using the Company's vBloc® Neurometabolic Therapy which will be broadcasted to attendees at ObesityWeek 2016 ( http://obesityweek.com/). Additionally, Scott Shikora, M.D., F.A.C.S., EnteroMedics' Executive Vice President and Chief Medical Officer, will co-moderate a panel discussion on Neuromodulation for Weight Loss, Metabolic Benefits and Gastroparesis. The conference, held by the American Society for Metabolic & Bariatric Surgery (ASMBS) and The Obesity Society (TOS), is taking place October 31 to November 4 in New Orleans, Louisiana.
Dr. Kukreja will perform the procedure during a live surgery session from 7:30-10:15 a.m. CT on Friday, November 4. The surgery will be performed on a patient for whom past gastric sleeve surgery failed to sustain weight loss benchmarks. Dr. Kukreja performed gastric sleeve rescue surgeries using vBloc Therapy in two US veterans in May 2016. Dr. Shikora will co-moderate the panel discussion from 4:15-6:00 p.m. CT on Wednesday, November 2. The panel will include presentations from trusted experts in the field of neuromodulation and will cover topics ranging from weight loss through vagal nerve blocking such as vBloc Therapy to gastroparesis. "As EnteroMedics continues to work towards obtaining nationwide coverage for our patient population, our presence at ObesityWeek 2016 will expose world-renowned experts in obesity to vBloc Therapy and the benefits it can provide to people living with morbid obesity," said Dan Gladney, EnteroMedics' President, Chief Executive Officer and Chairman of the Board. "We are honored to have vBloc Therapy chosen both as one of the three live surgical procedures to be broadcast to all attendees at ObesityWeek 2016, as well as having the opportunity to discuss neuromodulation and its role in treating obesity through the expert panel discussion." Dr. Kukreja added, "We are proud to offer veterans the option to use vBloc Therapy when other obesity treatments have failed. When co-morbidities prevent our patients from achieving a healthier lifestyle through traditional bariatric surgery, minimally-invasive salvage procedures such as vBloc Therapy can give them hope."